GW572016 In Patients With Advanced Or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: Tykerb
Sponsor: GlaxoSmithKline